categeory:watercooler Research models applied to GLP1s and Plateaus New research that shows a benefit to appetite feedback control circuits via mathematical modeling, showing the benefits of using GLP1s.
categeory:watercooler Novo's CEO will testify, but change is unlikely Novo's CEO goes to congress to testify, but not much is likely to change in the drug's pricing. We dive into some historical context.
categeory:watercooler Reminder: Ozempic face isn't real Ozempic face isn't real -- fast weight loss causes changes to the skin, and your face is a prime area that will change.
categeory:watercooler Life before GLP1s: Topiramate Wondering what the world was doing before GLP1s? We discuss Topiramate, a popular appetite suppressant.
category:news Are GLP1s primarily brain drugs? Are GLP1 Receptor Agonists (Ozempic, Wegovy, Mounjaro, etc) primarily brain drugs?
categeory:watercooler How much are people actually paying for GLP1s? We dive deep into the reports of people's GLP1 costs -- how much is the average person paying for Ozempic, Wegovy, Mounjaro, Zepbound and others?
categeory:watercooler What people get wrong about Ozempic We debunk some common misconceptions about GLP1 drugs like Ozempic, Wegovy, Mounjaro and others.
